ALBENZA (ALBENDAZOLE)
ALBENZA (ALBENDAZOLE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ALBENZA; Generic name: ALBENDAZOLE; Drug class: Anthelmintic [EPC].
| Brand name | ALBENZA |
|---|---|
| Generic name | ALBENDAZOLE |
| Drug class | Anthelmintic [EPC] |
| Manufacturer | Amneal Pharmaceuticals LLC |
| Used for | 1 INDICATIONS AND USAGE ALBENZA is an anthelmintic drug indicated for: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium . ( 1.1 ) Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus . ( 1.2 ) 1.1 Neurocysticercosis ALBENZA is indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium . 1.2 Hydatid Disease ALBENZA is indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tape |
| Dosage | 2 DOSAGE AND ADMINISTRATION Patients weighing 60 kg or greater, 400 mg twice daily; less than 60 kg, 15 mg/kg/day in divided doses twice daily (maximum total daily dose 800 mg). ALBENZA tablets should be taken with food. ( 2 ) Hydatid disease: 28-day cycle followed by 14-day albendazole-free interval for a total of 3 cycles. ( 2 ) Neurocysticercosis: 8 to 30 days. ( 2 ) See additional important information in the Full Prescribing Information. ( 2 ) 2.1 Dosage Dosing of ALBENZA will vary dependin |
| Active ingredient(s) | ALBENDAZOLE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1977a867-0ee1-44c0-8da3-fe59c48699f5 |